Les plaies tumorales en soins palliatifs

[1]  M. Falcou,et al.  A prospective, descriptive cohort study of malignant wound characteristics and wound care strategies in patients with breast cancer. , 2014, Ostomy/wound management.

[2]  U. Adderley,et al.  Topical agents and dressings for fungating wounds. , 2014, The Cochrane database of systematic reviews.

[3]  Y. De rycke,et al.  Bacterial Floras and Biofilms of Malignant Wounds Associated with Breast Cancers , 2013, Journal of Clinical Microbiology.

[4]  N. Cihoric,et al.  Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy , 2012, Radiation oncology.

[5]  C. Ostgathe,et al.  Fungating Wounds – Multidimensional Challenge in Palliative Care , 2011, Breast Care.

[6]  J. Kerihuel.  Effect of activated charcoal dressings on healing outcomes of chronic wounds. , 2010, Journal of wound care.

[7]  Clare Lazelle-Ali.  Psychological and physical care of malodorous fungating wounds. , 2007, British journal of nursing.

[8]  Julie W. Anderson,et al.  Managing Fungating Wounds , 2007, Advances in skin & wound care.

[9]  S. Seaman.  Management of malignant fungating wounds in advanced cancer. , 2006, Seminars in oncology nursing.

[10]  D. Mercier,et al.  Using topical aromatherapy for the management of fungating wounds in a palliative care unit. , 2005, Journal of wound care.

[11]  L. Adamsen,et al.  Qualitative and quantitative evaluation of a new regimen for malignant wounds in women with advanced breast cancer. , 2005, Journal of wound care.

[12]  C. Dowsett.  Malignant fungating wounds: assessment and management. , 2002, British journal of community nursing.

[13]  Jane Clark.  Metronidazole gel in managing malodorous fungating wounds. , 2002, British journal of nursing.

[14]  C. Ramlau,et al.  The effect of topical 0.75% metronidazole gel on malodorous cutaneous ulcers. , 1996, Journal of pain and symptom management.

[15]  G. Plant,et al.  METRONIDAZOLE IN SMELLY TUMOURS , 1980, The Lancet.